2026-03-15T21:30:28-05:00 2025-06-30 872525370 CITRIN COOPERMAN ADVISORS LLC 11400 WEST OLYMPIC BLVD 350 LOS ANGELES CA 90064 990 2024-07-01 223307141 THE PITUITARY SOCIETY INC PITU 3109889486 8700 BEVERLY BLVD 2051 LOS ANGELES CA 90048 DR SHLOMO MELMED SECRETARY-TREASURER 3109889486 2026-03-10 1 1 SHEILA MOGHIMI-KAMRAN P00170368 3104778355 2026-03-10 2024 2025-03-06 01:10:19Z DR SHLOMO MELMED 8700 BEVERLY BLVD 2051 LOS ANGELES CA 90048 753709 0 X N/A X 1994 DE TO PROVIDE SCIENTISTS, CLINICIANS AND TRAINEES WITH THE MOST UP-TO-DATE, RELIABLE RESEARCH AND EDUCATION ON THE BIOLOGY OF THE PITUITARY GLAND AND THE CAUSES, DIAGNOSIS AND TREATMENT OF PITUITARY GLAND RELATED DISEASES, IN ORDER TO IMPROVE PATIENT CARE AND TO PROVIDE A UNIQUELY INTERNATIONAL FORUM FOR PROFESSIONAL GROWTH AND SCIENTIFIC EXCHANGE. 13 13 0 63 0 0 413854 694053 66725 2230 63243 56433 7307 993 551129 753709 0 0 0 0 0 0 0 0 0 488822 483415 488822 483415 62307 270294 2128717 3079505 8745 689239 2119972 2390266 X OUR MISSION IS TO PROVIDE SCIENTISTS, CLINICIANS AND TRAINEES WITH THE MOST UP-TO-DATE, RELIABLE RESEARCH AND EDUCATION ON THE BIOLOGY OF THE PITUITARY GLAND AND THE CAUSES, DIAGNOSIS AND TREATMENT OF PITUITARY GLAND RELATED DISEASES, IN ORDER TO IMPROVE PATIENT CARE AND TO PROVIDE A UNIQUELY INTERNATIONAL FORUM FOR PROFESSIONAL GROWTH AND SCIENTIFIC EXCHANGE. 0 0 100100 2230 GROPRO CONFERENCETHE GROWTH HORMONE (GH)/ PROLACTIN (PRL) FAMILY IN BIOLOGY & DISEASE CONFERENCE (GROPRO) WAS HELD AUGUST 11-15, 2024, IN STIRLING, SCOTLAND. THIS CONFERENCE USED TO BE ASSOCIATED WITH FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY (FASEB) AND BEFORE THAT WITH THE GORDON CONFERENCES. SO, IT HAS LONG HISTORY, OVER 2 DECADES. THIS ITERATION OF THE CONFERENCE WAS HELD IN ASSOCIATION WITH THE PITUITARY SOCIETY. THIS CONFERENCE WAS HELD IN EUROPE FOR THE FIRST TIME WITH OVER 90 SCIENTISTS, PHYSICIANS, AND TRAINEES IN ATTENDANCE.THE SCIENTIFIC THEME OF THIS CONFERENCE IS TO IMPROVE OUR UNDERSTANDING OF THE REGULATION AND ACTION OF GH AND PRL AND THEIR SPECIFIC RECEPTORS AS WELL AS THEIR ROLE IN DISEASE PROMOTION OR PREVENTION. 18648 PRECEPTORSHIP COURSE FOR FELLOWS-IN-TRAININGTHIS COURSE, HELD IN JANUARY 2025, WAS THE SEVENTH SINCE ITS INCEPTION. THE COURSE WAS ATTENDED BY APPROXIMATELY 225 FELLOWS-IN-TRAINING. FELLOWS WERE REQUIRED TO SUBMIT AN INTERESTING PITUITARY CASE TO ATTEND THE COURSE. CASES WERE REVIEWED BY FACULTY AND FOUR-TO-SIX WERE SELECTED TO BE PRESENTED BY THE FELLOWS DURING THE CASE DISCUSSION. FACULTY RECORDED PRESENTATIONS ON ALL PITUITARY PATHOLOGY WERE VIEWED BY THE FELLOWS PRIOR TO THE LIVE WEBINARS TO ALLOW FOR MORE INTERACTIVE LEARNING.OVER THE LAST DECADE, MANY ENDOCRINOLOGY FELLOWSHIP PROGRAMS REDUCED THE TRAINING REQUIREMENTS FROM 3 YEARS TO 2 YEARS TO BE ELIGIBLE FOR BOARD CERTIFICATION. IN PARALLEL, DIABETES AND OBESITY INCIDENCE AND PREVALENCE INCREASED SIGNIFICANTLY, LIMITING CLINICAL EXPERIENCES ON OTHER RARER, NEVERTHELESS SEVERE AND POTENTIALLY LETHAL DISEASES, SUCH AS PITUITARY DISORDERS. THEREFORE, THIS COURSE TAUGHT BY LEADING INTERNATIONAL EXPERTS, ADDRESSED SOME OF THESE ISSUES BY REVIEWING FOR TRAINEES ADVANCEMENTS IN DIAGNOSIS AND TREATMENT OF HYPOPITUITARISM, GROWTH HORMONE DEFICIENCY, CUSHING'S SYNDROME AND ACROMEGALY AS WELL AS MANAGEMENT OF PITUITARY DISEASE IN THE POST-COVID ERA. 10000 PITUITARY SOCIETY CONSENSUS GUIDELINE FOR PITUITARY INCIDENTALOMAS (PUBLISHED GUIDELINE)WITHIN THE CONSTRAINTS OF LIMITED EVIDENCE-BASED REPORTS, THIS PITUITARY SOCIETY CONSENSUS SUMMARIZES THE EPIDEMIOLOGY AND NATURAL HISTORY, DIAGNOSTIC WORK-UP, AND TREATMENT OPTIONS FOR PATIENTS WITH PITUITARY INCIDENTALOMAS. WE DISTINGUISH BETWEEN PITUITARY ADENOMAS AND OTHER TYPES OF INCIDENTALOMAS AND PARTICULARLY DISTINGUISH BETWEEN MICROADENOMAS AND MACROADENOMAS GIVEN THE LOWER LIKELIHOOD OF THE LATTER TO BE A TRULY INCIDENTAL FINDING.THE GUIDELINES WERE PUBLISHED IN NATURE REVIEWS ENDOCRINOLOGY. 128748 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 13 13 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 CA X DR SHLOMO MELMED 3109889486 8700 BEVERLY BLVD 2051 LOS ANGELES CA 90048 X RICHARD ROSS MBBS MD FRCP PRESIDENT 6.00 X X 0 0 0 SHLOMO MELMED MB CHB MACP FRCP SECRETARY-TREASURER 6.00 X X 0 0 0 KEN HO MD CO-DIRECTOR, PROGRAMS 0.30 X X 0 0 0 MARIA FLESERIU MD FACE CO-DIRECTOR, PROGRAMS 0.30 X X 0 0 0 FELIPE F CASANUEVA MD PHD INTERNATIONAL RELATIONS 0.30 X X 0 0 0 ANDREA GIUSTINA MD EDITOR, PITUITARY 0.30 X X 0 0 0 NIENKE BIERMASZ MD PHD DIRECTOR 0.30 X 0 0 0 ELIZA GEERMD DIRECTOR 0.30 X 0 0 0 LISA NACHTIGALL MD DIRECTOR 0.30 X 0 0 0 ROSARIO PIVONELLO MD PHD DIRECTOR 0.30 X 0 0 0 GUDMUNDUR JOHANNSSON MD PHD DIRECTOR 0.30 X 0 0 0 ANN MCCORMACK MBBS DIRECTOR 0.30 X 0 0 0 KEVIN YUEN MD DIRECTOR 0.30 X 0 0 0 0 0 0 0 0 0 0 0 50225 643828 694053 MEETING REGISTRATION 611430 2230 2230 2230 56433 56433 CREDIT CARD REWARDS/DI 900099 993 993 993 753709 2230 0 57426 2495 2495 21850 21850 10870 10870 875 875 29173 15294 13879 10445 50 10395 5469 5469 72647 72647 7684 7684 SHARED EXPENSES - CEDAR 297489 297489 RECOGNITION AWARDS 14418 14418 PRECEPTOR COURSE 10000 10000 483415 128748 354667 0 18847 593876 1992848 2135242 107022 340387 10000 10000 2128717 3079505 8745 55927 0 633312 8745 689239 X 2119972 2390266 2119972 2390266 2128717 3079505 270294 0 X 0 0 0 X 1464 22450 433264 413854 694053 1565085 723830 262450 327460 66725 2230 1382695 725294 284900 760724 480579 696283 2947780 0 43076 314830 548112 906018 43076 314830 548112 906018 2041762 338 137 27475 63243 56433 147626 338 137 27475 63243 56433 147626 2092 9896 7306 993 20287 725632 287129 798095 551128 753709 3115693 0.65530 0.83110 0.04740 0.03460 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 REVENUE RECEIVED IN ADVANCE - CONGRESS 633312 633312 FORM 990, PART VI, SECTION B, LINE 11B THE ORGANIZATION PROVIDES EACH MEMBER OF ITS GOVERNING BODY WITH THE FORM 990, BEFORE IT IS FILED, FOR THEIR REVIEW AND ULTIMATE APPROVAL FOR FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION REQUIRES AN ANNUAL RE-EXAMINATION OF CONFLICT OF INTEREST, WHEREBY THE BOARD OF DIRECTORS AND ALL OFFICERS NEED TO SIGN A FORM VERIFIYING THAT THERE ARE NO CONFLICTS OR IF THERE ARE, DISCLOSING THEM. THE ORGANIZATION THEN MONITORS THE DECISION MAKING PROCESS TO ENSURE IT IS NOT TAINTED BY POTENTIAL CONFLICT. FORM 990, PART VI, SECTION C, LINE 19 ALL GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE HELD BY THE DIRECTOR AND ARE AVAILABLE FOR THE PUBLIC TO REVIEW AT ANY TIME.